<DOC>
	<DOC>NCT01591512</DOC>
	<brief_summary>The purpose of this study is to collect samples to evaluate the ProGRP and NSE assays independently as aids for monitoring the course of disease and therapy in subjects diagnosed with SCLC.</brief_summary>
	<brief_title>A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<criteria>Age â‰¥ 18 Confirmed diagnosis of SCLC or mixed SCLC/nonSCLC per histopathology results Scheduled to undergo first, second or thirdline treatment for SCLC, including chemotherapy, chemotherapy + radiation therapy, or combined concurrent chemoradiotherapy. Able to understand and willing to provide Informed Consent No diagnosis of SCLC Not scheduled to undergo treatment for the diagnosis of SCLC Unable to provide Informed Consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Small Cell Lung Cancer</keyword>
	<keyword>SCLC</keyword>
	<keyword>Lung Cancer</keyword>
	<keyword>Subjects diagnosed with SCLC who will undergo treatment</keyword>
</DOC>